SCHEMBL13955072

SCHEMBL13955072

CCn1c(N(C)CC(C)(C)N)nc2c1c(=O)n(Cc1nc(C)nc3ccccc13)c(=O)n2C

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.39
ALDH1A1 P00352 2/20 0.39
TSHR P16473 2/20 0.39
MAPK1 P28482 2/20 0.39
NPSR1 Q6W5P4 1/20 0.39
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
POLB P06746 1/20 0.38
CTDSP1 Q9GZU7 1/20 0.38
DPP4 P27487 6/20 0.37
FAP Q12884 2/20 0.37
POU2F2 P09086 1/20 0.36
ADORA3 P0DMS8 1/20 0.36
CHRM1 P11229 1/20 0.36
POU2F1 P14859 1/20 0.36
CHRM3 P20309 1/20 0.36
HRH2 P25021 1/20 0.36
MC4R P32245 1/20 0.36
DPP8 Q6V1X1 1/20 0.36
DPP9 Q86TI2 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8273227 0.90 DPP4 (0.46) DPP4FAPPOU2F2ADORA3CHRM1
SCHEMBL13955141 0.87 DPP4 (0.48) MAPTALDH1A1TSHRMAPK1NPSR1
SCHEMBL2976376 0.87 DPP4 (0.50) MAPTALDH1A1TSHRMAPK1NPSR1
SCHEMBL13955071 0.82 KMT2A (0.38) MAPTALDH1A1TSHRMAPK1NPSR1
SCHEMBL8272337 0.81 MAPT (0.40) MAPTALDH1A1TSHRMAPK1NPSR1
SCHEMBL13955073 0.81 DPP4 (0.41) MAPTALDH1A1TSHRMAPK1NPSR1
SCHEMBL19154499 0.80 DPP4 (0.48) MAPTALDH1A1TSHRMAPK1NPSR1
SCHEMBL13955108 0.79 ALDH1A1 (0.42) MAPTALDH1A1TSHRMAPK1NPSR1
SCHEMBL13955123 0.79 DPP4 (0.51) MAPTALDH1A1TSHRMAPK1NPSR1
SCHEMBL13955210 0.79 PKM (0.39) MAPTALDH1A1TSHRMAPK1NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7495002-B2 3-methyl-7-butinyl-xanthines, the preparation thereof and their use as pharmaceutical compositions BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-02-24 US disclosed